RedHill Biopharma (RDHL) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
RedHill Biopharma has announced its Annual General Meeting of Shareholders to be held on September 17, 2024, where it will discuss the appointment of auditors, re-election and election of board members, and approval of restricted share units for directors and officers. Shareholders as of August 6, 2024, will be eligible to vote, and are encouraged to do so by proxy if they cannot attend in person. The meeting will address the company’s performance and strategic directions, including executive compensations and the granting of share units.
For further insights into RDHL stock, check out TipRanks’ Stock Analysis page.